Attogene

Executive Summary

Attogene is a biomanufacturing and diagnostics company headquartered in Austin, Texas, focused on developing accessible detection technologies for environmental toxins, food safety, and viral pathogens. Founded in 2013, the company leverages platforms such as lateral flow, ELISA, and PCR to create assays that bridge complex scientific innovation with real-world monitoring needs. With a mission to democratize health and environmental monitoring, Attogene targets both point-of-care and central laboratory markets, aiming to provide rapid, accurate, and cost-effective solutions. The company operates as a private entity and has not disclosed funding details or valuation, suggesting a lean operation focused on commercialization and strategic partnerships.

Upcoming Catalysts (preview)

• Q4 2026Launch of a new multiplex lateral flow assay for foodborne pathogens60% success
• Q1 2027FDA 510(k) clearance for a rapid viral detection kit40% success
• Q2 2027Strategic partnership or distribution agreement with a global diagnostics firm50% success